Document is current
Any future updates will be listed below
-
Authors
Cui, Ju
Gu, Yujia
Pang, Jing
Gao, Huafang
Zhang, Li-Qun
Wu, Xiaolan
Dang, Junwu
Li, Juan
Zhu, Xinyi
Luo, Senlin
Wang, Zhao
Tu, Fuyi
Zhang, Likun
Liu, Yang
Yang, Guangyu
Zhang, Qin
Wang, Wanxia
Tian, Wen
Li, Weimin
Xiong, Wei
Zhang, Xuewei
Lin, Zhanyi
Zheng, Songbai
Dai, Lunzhi
Wang, Xiaoming
Lu, Zhongqiu
Sun, Xiaohong
Cai, Jianping
Ma, Wei
Zhang, Tiemei
-
Funding
Funding for this research was provided by:
National High-Level Hospital Clinical Research Funding (BJ-2024-219)
National High Level Hospital Clinical Research Funding (BJ-2024-138)
The National Key Research and Development Program of China (2018YFC2000300)
The National Key Research and Development Program of China (2020YFC2002700)
Chinese Academy of Medical Sciences Initiative for Innovative Medicine (No. 2021-I2M-1-050)
- License Information
-
More Information
Article History
Received: 4 September 2025
Accepted: 15 January 2026
First Online: 25 February 2026
Declarations
:
: The protocol of PENG ZU cohort study was reviewed and approved by the Research Ethics Committee of Beijing Hospital (Approval No.: 2019BJYYEC- 054-02). Written informed consent was obtained from all participants. The study was performed in accordance with the principles of the Declaration of Helsinki.
: The authors declare no competing interests.
